Abstract:Background: Continuous understanding of the epidemiology and evolution of multidrug resistant TB (MDR-TB) is key to develop the appropriate strategies for preventing its epidemic. The present study aimed to investigate the longitudinal trend of its rates, transmissions and transition to extensively drug resistant TB(XDR-TB), in an attempt to adjust the TB control activities in eastern rural China. Methods: The data presented here span 8 years (2003-2010) and consisted of three population-based investigation of drug resistant TB in terms of socio-demographic and clinical characteristics of drug resistant TB cases as well as the microbiological and molecular features of their infected Mtb strains, respectively in one 19 years’ DOTS covered eastern rural county: Deqing (DQ) and the other 9 years’ DOTS covered Guanyun (GY). Results: Within 9 years’ study, 901 TB patients were identified at local TB dispensaries in two counties, with 254 resistant to at least one of 1st line drugs. Of the 135 MDR-TB isolates, 6 were XDR-TB. Rate of drug resistant TB remained stable, even reduced in some period both in two counties, while the rate of MDR-TB and MDR-TB plus resistance to fluoroquinolones increased significantly respectively from 14.5% and 5.1% in 2003/2004 to 21.3% and 9.7% in 2009/2010. The IS6110 RFLP genotyping revealed the 21 clusters involving 48(28.4%) drug resistant TB cases in DQ and 28 clusters involving 59(32.1%) drug resistant TB cases in GY. The clustering proportion increased among the drug resistant TB cases especially for MDR-TB over the study period, reaching 52%(DQ) and 48%(GY) in 2010. And 2 XDR-TB isolates was identified within only 2 clusters 0f drug resistant Mtb in DQ. Designated as subtypes of Beijing family, totally 3 clusters (11 drug resistant TB cases) typical with katG315Thr mutation, persisted throughout the study period in two counties. Conclusion: A high increased recent transmission of MDR-TB might implicate it necessary to improve the effectiveness on diagnosis and treatment of MDR-TB. Despite an increasing trend of MDR plus the resistant to fluoroquinolones, the low proportion of XDR-TB among MDR-TB might indicate it neccessary to cautiously introduce some of 2 line drugs in MDR-TB treatment in China.

Genome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone.

Genome-Wide Expression Profiling of the Response to Linezolid in Mycobacterium tuberculosis

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Global Transcriptional Profiles of Mycobacterium Tuberculosis Treated with Plumbagin

The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis

Genome-wide DNA Methylation and Transcriptome Changes in Mycobacterium Tuberculosis with Rifampicin and Isoniazid Resistance.

Potential Genes Related to Levofloxacin Resistance in Mycobacterium Tuberculosis Based on Transcriptome and Methylome Overlap Analysis

Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice

Gene expression profile analysis and target gene discovery of Mycobacterium tuberculosis biofilm

DNA microarray gene expression profile of Mycobacterium tuberculosis when exposed to osthole.

Meta-analysis of Human Gene Expression in Response to Mycobacterium Tuberculosis Infection Reveals Potential Therapeutic Targets.

Adaptive Gene Profiling of Mycobacterium Tuberculosis During Sub-Lethal Kanamycin Exposure

Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis suscepitibility

Gene Expression Analysis of Two Extensively Drug-Resistant Tuberculosis Isolates Show That Two-Component Response Systems Enhance Drug Resistance

Genome-wide Transcriptional Profiling Identifies Potential Signatures in Discriminating Active Tuberculosis from Latent Infection

Multi-omics-based characterization of the influences of Mycobacterium tuberculosis virulence factors EsxB and PPE68 on host cells

Mycobacterium Tuberculosis Biology Revealed by Proteome Profiling and Integration of Multi-Omics Data-Proteomics Insight into M-Tuberculosis Systems Biology

Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis

An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium Tuberculosis Infection.

Novel Biomarkers Distinguishing Active Tuberculosis From Latent Infection Identified By Gene Expression Profile Of Peripheral Blood Mononuclear Cells

CRISPR Screening and Comparative LC‐MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis